Get the Stockscreener App
0.00
100.00%
-0.41
Clearside Biomedical Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
See More
Previous Close:
$0.41
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$2.15M
Revenue:
$4.17M
Net Income/Loss:
$-27.71M
P/E Ratio:
0.00
EPS:
-0.37
Net Cash Flow:
$-22.23M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$17.10
Clearside Biomedical Inc Stock (CLSD) Company Profile
Name
Clearside Biomedical Inc
Sector
Industry
Phone
678-270-3631
Address
900 NORTH POINT PARKWAY, ALPHARETTA, GA
Compare CLSD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLSD
Clearside Biomedical Inc
|
0.00 | 2.15M | 4.17M | -27.71M | -22.23M | -0.37 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-25 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jul-18-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-18-25 | Downgrade | Stifel | Buy → Hold |
| Aug-21-24 | Initiated | Chardan Capital Markets | Buy |
| Jun-25-24 | Initiated | Oppenheimer | Outperform |
| Dec-15-21 | Resumed | Wedbush | Outperform |
| Jul-29-21 | Initiated | H.C. Wainwright | Buy |
| May-13-20 | Initiated | ROTH Capital | Buy |
| Aug-09-19 | Downgrade | Needham | Buy → Hold |
| Nov-05-18 | Downgrade | Cowen | Outperform → Market Perform |
| Nov-05-18 | Downgrade | JP Morgan | Overweight → Underweight |
| Nov-05-18 | Downgrade | Stifel | Buy → Hold |
| Mar-06-18 | Reiterated | Needham | Buy |
| May-25-17 | Initiated | JMP Securities | Mkt Outperform |
| Feb-24-17 | Initiated | JP Morgan | Overweight |
| Nov-10-16 | Reiterated | Needham | Buy |
| Oct-24-16 | Reiterated | Stifel | Buy |
View All
Clearside Biomedical Inc Stock (CLSD) Latest News
How Clearside Biomedical Inc. (CLM) stock stacks up against competitors2025 Winners & Losers & Fast Exit and Entry Strategy Plans - Newser
Is Clearside Biomedical Inc. (CLM) stock undervalued at current priceJuly 2025 Trends & Community Consensus Trade Alerts - Newser
How Clearside Biomedical Inc. (CLM) stock performs in easing cyclesWeekly Volume Report & Low Risk Entry Point Tips - Newser
Is Clearside Biomedical Inc. stock positioned for digital transformation2025 Key Highlights & High Return Stock Watch Alerts - Newser
Why Clearside Biomedical Inc. (CLM) stock trades below fair valuePortfolio Return Summary & Weekly Momentum Picks - Newser
Is Clearside Biomedical Inc. (CLM) stock attractive for dividend growthQuarterly Trade Report & Comprehensive Market Scan Insights - Newser
Is Clearside Biomedical Inc. (CLM) stock supported by strong fundamentalsQuarterly Growth Report & Verified Trade Idea Suggestions - Newser
Can Clearside Biomedical Inc. (CLM) stock beat analyst consensusPortfolio Value Summary & Real-Time Stock Entry Alerts - Newser
Meet The Attorneys Leading Clearside Biomedical's Ch. 11 - Law360
A better buy-in window may exist right now for Clearside Biomedical Inc (CLSD) - Setenews
Clearside Biomedical (CLSD) Options Delisted as of December 1 - GuruFocus
Published on: 2025-11-30 08:17:47 - BỘ NỘI VỤ
What drives Clearside Biomedical Inc stock priceDay Trading Setups & Explosive Growth Opportunities - earlytimes.in
Why Clearside Biomedical Inc. stock remains on buy listsInsider Selling & Long-Term Growth Plans - BỘ NỘI VỤ
Clearside Biomedical, Inc.(NasdaqGM: CLSD) dropped from S&P TMI Index - marketscreener.com
Is Clearside Biomedical Inc CLM a good long term investmentMarket Volatility Update & Superior Trading Ideas - earlytimes.in
Clearside Biomedical Faces Delisting After Bankruptcy Filing - MSN
Clearside Biomedical to pursue sale of business via Chapter 11 process - MSN
Catching Up With New Bankruptcy Case Action - Law360
Biomedical Co. Gets First-Day Ch. 11 Relief Amid Sale Push - Law360
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Health Care Stocks Climb As Inspire Medical Shines - Finimize
Stocks of Clearside Biomedical Inc (CLSD) are poised to climb above their peers - Setenews
Key medical device brand for files Chapter 11 bankruptcy - TheStreet
Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process - VisionMonday.com
CLSD Stock Crashes Over 60% Today as Clearside Biomedical Files for Chapter 11 Bankruptcy - ts2.tech
Clearside Biomedical files for Chapter 11 bankruptcy protection By Investing.com - Investing.com Australia
Health care brand saving eyesight files Chapter 11 bankruptcy - Yahoo Finance
Clearside Biomedical Filed for Chapter 11 - USA Herald
Georgia Based Well known HealthCare Company files chapter 11 Bankruptcy - WhatNow
CLSD Stock Plummets After Company Files For Bankruptcy Protection - Asianet Newsable
Ophthalmic Co. Hits Ch. 11 With $64M Debt, Eyeing Sale - Law360
Clearside Biomedical plunges after filing for Chapter 11 bankruptcy - TradingView
Nasdaq Surges 350 Points; Enlivex Therapeutics Shares Spike Higher - Benzinga
Clearside Biomedical to pursue sale of its business through voluntary Chapter 11 process - MarketScreener
Clearside Biomedical Files For Chapter 11 Bankruptcy - Nasdaq
Clearside Biomedical (CLSD) Files for Chapter 11 Bankruptcy - GuruFocus
Clearside Biomedical files for Chapter 11 bankruptcy protection - Investing.com
Morning Market Movers: CLSD, CJET, TWNP, JXG See Big Swings - RTTNews
Why Is Clearside Biomedical Stock (CLSD) Down Today? - TipRanks
Clearside Biomedical (CLSD) Initiates Chapter 11 Bankruptcy Proc - GuruFocus
Clearside Biomedical Voluntary Files Petition For Chapter 11 Bankruptcy - Nasdaq
Clearside Biomedical files for Chapter 11 (CLSD:NASDAQ) - Seeking Alpha
Clearside Biomedical, Inc. Files Chapter 11 Bankruptcy to Pursue Asset Sale and Maximize Stakeholder Value - Quiver Quantitative
Clearside Biomedical to Pursue Strategic Sale of Its Business Through Voluntary Chapter 11 Process - marketscreener.com
Clearside Biomedical plunges after filing for bankruptcy - TradingView
Clearside Biomedical (CLSD) Stock Price, Quote, News & History - Benzinga
Clearside Biomedical files for Chapter 11 bankruptcy in UScourt filing - marketscreener.com
Clearside Biomedical Files For Chapter 11 Bankruptcy In USCourt Filing - TradingView
Clearside Biomedical Inc Stock (CLSD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.44%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):